Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT05609370What this trial is testingA Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal CancerWho this might be right forUnresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer BeiGene 113
Testing effectiveness (Phase 2)UnknownNCT03992456What this trial is testingPanitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal CancerWho this might be right forMetastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+27 more Academic and Community Cancer Research United 12
Testing effectiveness (Phase 2)Study completedNCT03981614What this trial is testingBinimetinib and Palbociclib or TAS-102 in Treating Patients With KRAS and NRAS Mutant Metastatic or Unresectable Colorectal CancerWho this might be right forMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8+3 more Academic and Community Cancer Research United 102
Early research (Phase 1)Active Not RecruitingNCT04704661What this trial is testingTesting the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialWho this might be right forAdvanced Breast CarcinomaAdvanced Colon CarcinomaAdvanced Colorectal Carcinoma+37 more National Cancer Institute (NCI) 51
Not applicableStudy completedNCT04926376What this trial is testingSafety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)Who this might be right forHepatocellular Carcinoma Non-resectableMetastatic Colorectal CancerLiver Cancer ABK Biomedical 8
Testing effectiveness (Phase 2)Ended earlyNCT00003485What this trial is testingAntineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon CancerWho this might be right forColon Cancer Burzynski Research Institute 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05308446What this trial is testingTesting the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF MutationWho this might be right forMetastatic Colon AdenocarcinomaMetastatic Rectal AdenocarcinomaStage III Colon Cancer AJCC v8+5 more National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07815288What this trial is testingRetlirafusp Alfa Plus Targeted Therapy and Chemotherapy for Unresectable Colorectal Liver-Limited MetastasesWho this might be right forColorectal Adenocarcinoma Metastatic in the Liver Peking University Cancer Hospital & Institute 80
Testing effectiveness (Phase 2)Looking for participantsNCT06634875What this trial is testingIsunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)Who this might be right forColorectal Cancer Metastatic Buzzard Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT02063529What this trial is testingFOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Sun Yat-sen University 101
Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00700570What this trial is testingAvastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal CancerWho this might be right forColorectal Cancer Hoffmann-La Roche 45
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Testing effectiveness (Phase 2)Study completedNCT03721653What this trial is testingFOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer PatientsWho this might be right forMetastatic Colorectal Cancer Gruppo Oncologico del Nord-Ovest 218
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07621497What this trial is testingFOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)Who this might be right forMetastatic Colorectal Cancer (CRC) Sun Yat-sen University 229
Early research (Phase 1)Ended earlyNCT05769959What this trial is testingStudy of RO7515629 in Participants With HLA-G Positive Solid TumorsWho this might be right forRenal Cell CarcinomaNon-small Cell Lung CancerPancreatic Adenocarcinoma+2 more Hoffmann-La Roche 3
Testing effectiveness (Phase 2)Study completedNCT03164655What this trial is testingImproving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy NetworkWho this might be right forColorectal Cancer Metastatic UNICANCER 20
Early research (Phase 1)Active Not RecruitingNCT05848739What this trial is testingA Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid TumorsWho this might be right forColon CancerMetastatic Colon Cancer Sapience Therapeutics 130